Non-pharmacological treatment of depression: a systematic review and evidence map
BackgroundThe comparative effectiveness of non-pharmacological treatments of depression remains unclear.MethodsWe conducted an overview of systematic reviews to identify randomised controlled trials (RCTs) that compared the efficacy and adverse effects of non-pharmacological treatments of depression...
Gespeichert in:
Veröffentlicht in: | Evidence-based medicine (English ed.) 2016-12, Vol.21 (6), p.214-221 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BackgroundThe comparative effectiveness of non-pharmacological treatments of depression remains unclear.MethodsWe conducted an overview of systematic reviews to identify randomised controlled trials (RCTs) that compared the efficacy and adverse effects of non-pharmacological treatments of depression. We searched multiple electronic databases through February 2016 without language restrictions. Pairs of reviewers determined eligibility, extracted data and assessed risk of bias. Meta-analyses were conducted when appropriate.ResultWe included 367 RCTs enrolling ∼20 000 patients treated with 11 treatments leading to 17 unique head-to-head comparisons. Cognitive behavioural therapy, naturopathic therapy, biological interventions and physical activity interventions reduced depression severity as measured using standardised scales. However, the relative efficacy among these non-pharmacological interventions was lacking. The effect of these interventions on clinical response and remission was unclear. Adverse events were lower than antidepressants.LimitationThe quality of evidence was low to moderate due to inconsistency and unclear or high risk of bias, limiting our confidence in findings.ConclusionsNon-pharmacological therapies of depression reduce depression symptoms and should be considered along with antidepressant therapy for the treatment of mild-to-severe depression. A shared decision-making approach is needed to choose between non-pharmacological therapies based on values, preferences, clinical and social context. |
---|---|
ISSN: | 1356-5524 1473-6810 |
DOI: | 10.1136/ebmed-2016-110522 |